Detalles de la búsqueda
1.
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
N Engl J Med
; 388(17): 1547-1558, 2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36912538
2.
Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against.
Br J Cancer
; 130(1): 3-8, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38030748
3.
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
JAMA
; 331(17): 1460-1470, 2024 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581198
4.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142371
5.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953525
6.
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(4): 501-513, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279270
7.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411939
8.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671327
9.
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
BJU Int
; 130(3): 370-380, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373443
10.
Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative exploration.
Support Care Cancer
; 29(3): 1317-1325, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32632762
11.
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer.
Br J Cancer
; 123(7): 1063-1070, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32669672
12.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578639
13.
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.
BJU Int
; 125(4): 506-514, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31900963
14.
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
Lancet Oncol
; 20(3): 436-447, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30713036
15.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355464
16.
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
N Engl J Med
; 375(15): 1415-1424, 2016 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27626136
17.
Correction: YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells.
J Transl Med
; 22(1): 20, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38178184
18.
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.
BMC Cancer
; 19(1): 947, 2019 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31615476
19.
Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.
Qual Life Res
; 28(10): 2741-2751, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31115843
20.
Patients' and partners' views of care and treatment provided for metastatic castrate-resistant prostate cancer in the UK.
Eur J Cancer Care (Engl)
; 28(6): e13140, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31475410